Related Experiment Video
Updated: Jul 1, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
In Silico and In Vitro Elucidation of the Inhibitory Mechanism of Chlorogenic Acid Against Helicobacter pylori Urease
Luzhe Wu1, Shengyao Hou1, Hongguang Cao2
1School of Pharmacy Binzhou Medical University Yantai Shandong China.
None:
Chlorogenic acid (CGA), a phenolic compound widely distributed in plants, has exhibited inhibitory activity against Helicobacter pylori (H. pylori) by effectively suppressing urease, a key virulence factor of the pathogen. This study aimed to investigate the binding affinity between CGA and urease and explore the underlying molecular mechanism. Inhibition kinetics were characterized using Lineweaver-Burk plots, fluorescence quenching, isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR). The binding mode was elucidated using molecular docking and molecular dynamics simulations. The results demonstrated that CGA exhibited a mixed-type inhibition against H. pylori urease (HPU). CGA quenched the intrinsic fluorescence of HPU via a static quenching mechanism, with the quenching constant (K q) of 0.41 ± 0.04 × 1013 M-1 s-1. The thermodynamic parameters indicated that the interaction between CGA and HPU was exothermic and enthalpy-driven (ΔG < 0, ΔH < 0). SPR data revealed that CGA had a dissociation constant (K D) of 1.63 ± 0.19 × 10-5 M. CGA bound to HPU near the active site and flap region, forming a stable complex. These findings contribute to the understanding of phenolics in anti-H. pylori therapy and highlight CGA as a promising lead compound for the development of innovative urease-targeted applications.
More Related Videos
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists